LabCompass

Yutaka Endo

Medicine · The Ohio State University

Established · publishing since 1972Rising activity

Publications

408

Citations

4,138

Est. group size

~15

Recurring co-author estimate

Active years

55

Publishing since 1972

Research summary
AI-generated

Yutaka Endo works in surgical oncology and transplant medicine, with a focus on liver, pancreatic, and gastric cancers. Much of the work centers on liver transplantation—including for cancers that spread to the liver from other organs (like colorectal cancer)—organ donation practices, and outcomes for patients undergoing complex cancer surgeries. The research often draws on large multi-institutional databases and registries to study treatment outcomes and improve clinical decision-making.

Liver transplantation and organ donationLiver, pancreatic, and gastric cancer treatment outcomesColorectal cancer metastasis to the liverMachine learning applications in transplant medicinePostmarketing drug safety surveillance

Publication output has grown substantially, rising sharply from single digits per year before 2022 to over 100 publications in 2023, suggesting a strongly increasing rate of research activity in recent years.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 54.2/year recently
2017: 6 publications172018: 9 publications182019: 9 publications192020: 6 publications202021: 6 publications212022: 29 publications222023: 102 publications102232024: 86 publications242025: 53 publications252026: 1 publication26
Recent publications
Publishes in
  • Annals of Surgical Oncology×92
  • HPB×32
  • Journal of Gastrointestinal Surgery×30
  • Surgery×19
  • Journal of Surgical Oncology×15
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile